CRC
GSK icon

Curi RMB Capital’s GSK GSK Stock Holding History

Curi RMB Capital’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-13,902
Closed -$750K – 503
2016
Q3 		$750K Sell
13,902
-22,339
-62% -$1.22M 0.04% 270
2016
Q2 		$1.96M Sell
36,241
-15,113
-29% -$796K 0.1% 172
2016
Q1 		$2.6M Buy
51,354
+7,588
+17% +$378K 0.17% 146
2015
Q4 		$2.21M Sell
43,766
-9,991
-19% -$509K 0.1% 157
2015
Q3 		$2.58M Sell
53,757
-629
-1% -$32.7K 0.17% 141
2015
Q2 		$2.83M Buy
54,386
+6,504
+14% +$366K 0.18% 125
2015
Q1 		$2.76M Buy
47,882
+2,884
+6% +$165K 0.17% 139
2014
Q4 		$2.4M Sell
44,998
-5,925
-12% -$331K 0.15% 155
2014
Q3 		$2.93M Buy
50,923
+9,125
+22% +$559K 0.18% 135
2014
Q2 		$2.79M Sell
41,798
-1,513
-3% -$102K 0.18% 139
2014
Q1 		$2.89M Buy
43,311
+249
+0.6% +$16.8K 0.2% 123
2013
Q4 		$2.87M Buy
43,062
+1,257
+3% +$81.5K 0.2% 116
2013
Q3 		$2.62M Sell
41,805
-270
-0.6% -$17.4K 0.19% 133
2013
Q2 		$2.63M Buy
+42,075
New +$2.67M 0.2% 121

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Curi RMB Capital's GSK Position: Q4 2016 in Review

Curi RMB Capital sold out of GSK (GSK) in Q4 2016, closing a stake of 13,902 shares — an estimated $750K sold.

Curi RMB Capital first reported a position in GSK in Q2 2013 and held it in 14 quarters. The position peaked at $2.93M in Q3 2014. 762 funds tracked by Wall St. Rank hold GSK as of Q4 2016.

  • Curi RMB Capital reported no remaining GSK position as of Q4 2016 after selling out during the quarter.
  • Curi RMB Capital sold 13,902 GSK shares in Q4 2016, an estimated $750K.
  • Curi RMB Capital first reported a position in GSK in Q2 2013 and held it in 14 quarters.
  • Curi RMB Capital's GSK position peaked at $2.93M in Q3 2014.
  • 762 funds tracked by Wall St. Rank held GSK as of Q4 2016.

Based on Curi RMB Capital's 13F filing for Q4 2016, filed 13 Feb 2017.